№ lp_1_15259
File format: docx
Character count: 2724
File size: 1082 KB
Clinical referral guidance and structured medical referral source outlining urgent and routine pathways, required clinical data, and multidisciplinary management processes for diabetic foot ulceration within NHS community and hospital services.
Year:
2025
Date:
7 April 2025
Region / City:
Swindon and Wiltshire, Gloucestershire
Country:
United Kingdom
Healthcare System:
NHS
Clinical Area:
Diabetes foot care
Topic:
Diabetic foot ulcer referral pathways
Document Type:
Clinical referral guidance and referral form
Issuing Organizations:
Gloucestershire Hospitals NHS Foundation Trust; Wiltshire Community Podiatry; Swindon Community Podiatry
Target Audience:
General practitioners, community podiatrists, healthcare professionals
Referral Pathways:
Same Day Emergency Care (SDEC); Foot Attack Clinic; Community Podiatry; Vascular Surgery
Urgency Categories:
Urgent referrals; Routine referrals
Associated Services:
Diabetes Foot MDT; Community Diabetes Teams
Clinical Conditions Covered:
Diabetic foot ulceration; infection; ischaemia; Charcot foot; neuropathy
Required Clinical Information:
Patient demographics; diabetes history; comorbidities; ulcer characteristics; investigations; treatments
Investigations Referenced:
Blood tests; wound swab; tissue sample; X-ray; ultrasound
Contact Methods:
Email referrals; ERS submissions; telephone
Period of Applicability:
Ongoing as of April 2025
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2023
Region / city:
United Kingdom
Topic:
Nursing care plan, Pressure ulcers
Document type:
Medical protocol
Organization / institution:
NHS Forth Valley
Author:
Not specified
Target audience:
Healthcare professionals (nurses, doctors)
Period of validity:
Not specified
Approval date:
Not specified
Date of revisions:
Not specified
Note:
Clinical area
Healthcare setting:
Inpatient and community nursing
Topic:
Pressure ulcer prevention and incident review
Document type:
Clinical assessment and review record
Assessment focus:
Skin inspection, pressure ulcer risk, SSKIN interventions, nutrition, continence
Care bundle referenced:
SSKIN
Related reporting system:
Datix
Patient considerations:
Vulnerable person safeguarding, mobility, equipment needs
Review outcome categories:
Avoidable or unavoidable pressure ulcer
Follow-up actions:
Learning points, action plan, duty of candour review
Year:
2024
Country:
Scotland
Healthcare system:
NHS
Subject:
Venous leg ulcer management and intervention
Document type:
Clinical pathway and Standard Operating Procedure
Issuing programme:
National Wound Care Strategy Programme
Clinical setting:
Community Venous Leg Ulcer Clinic and Vascular Surgery Service
Target population:
Patients with venous leg ulcers
Related guidance:
NICE guidance; SIGN 120 (withdrawn)
Referenced trials:
ESCHAR trial (2007); EVRA trial (2018)
Contributors:
NHS Tayside clinical team (appendix adaptation)
Services involved:
Primary Care, District Nursing, Vascular Surgery, Dermatology
Procedures included:
ABPI measurement, compression therapy, venous duplex, endovenous ablation, sclerotherapy, surgical stripping
Referral pathway:
Community clinic triage and one-stop vascular clinic referral
Period of applicability:
From July 2024
Year:
2022
Region / city:
Riyadh, Saudi Arabia
Subject:
Medicine, Surgery
Document Type:
Case Report
Author:
Nasser Alzerwi
Target Audience:
Medical professionals, surgeons
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Version:
7.0
Year:
2024
Region / City:
England
Topic:
Leg Ulcer Prevention and Management
Document Type:
Procedural Document
Institution:
ELFT
Author:
Caroline Dowsett, Clinical Nurse Specialist Tissue Viability and Clinical Lead Leg Ulcer Service
Target Audience:
Healthcare professionals
Approval Date:
5th July 2024
Ratification Date:
25th September 2024
Implementation Date:
September 2024
Last Review Date:
June 2024
Next Review Date:
June 2027
Applicable to:
Trust wide, Community Health Services, Mental Health and LD
Predecessor:
Leg Ulcer Prevention and Management Guidelines 2021
Related Documents:
Wound Management Guideline, Infection Control Policy
Review Responsibility:
Clinical Lead for Leg Ulcer Service Tissue Viability Service
Publication Date:
April 2025
Review Date:
April 2027
Supersedes:
Island-Wide Pressure Ulcer Prevention and Management Framework 2021
Ratification:
Health & Care Jersey (HCJ) Policy and Procedure Ratifying Group; Family Nursing & Home Care (FNHC) Organisational Governance Approval Group
Review Cycle:
Every two years
Geographical Scope:
Jersey
Thematic Area:
Prevention and management of pressure ulcers
Document Type:
Clinical framework and standards document
Applicable To:
Health and social care services and organisations
Target Population:
Individuals of all ages at risk of or identified with pressure ulcers, including babies and children
Source Standards:
Health Improvement Scotland Standards for Prevention and Management of Pressure Ulcers 2020
Referenced Authority:
NHS Improvement (2019) Pressure Ulcer Categorisation
Key Components:
Leadership and governance; staff education and training; person centred information and support; risk assessment and reassessment; care planning; safeguarding procedures; clinical pathway guidance
Safeguarding Provisions:
Adult and children safeguarding procedures including reporting and decision guides
Note:
Year
Note:
Year
Topic:
Medical assessment
Document type:
Questionnaire
Target audience:
Medical professionals
Note:
Year
Topic:
Healthcare
Document Type:
Protocol
Target Audience:
Healthcare professionals
Contextual Description:
A protocol outlining the process for documenting and assessing skin damage using a body map in a healthcare setting.
Year:
2010–2011
Region / City:
Philadelphia, PA, USA
Subject:
Peptic Ulcer Disease, Gastritis, Nutrition Therapy
Document Type:
Case Study
Institution:
W.B. Saunders Company, Thomson Brooks/Cole, MedlinePlus, RxList
Author:
L.K. Mahan, S. Escott-Stump, M. Nelms, K. Sucher, K. Lacey, D. Habash, S. Roth
Target Audience:
Medical and nutrition students, healthcare professionals
Period Covered:
2010–2011
Medications Discussed:
Carafate, AlternaGel, Pepcid, Nexium, Amoxicillin, Clarithromycin
Risk Factors:
NSAID use, alcohol, tobacco, stress, poor nutrition
Symptoms:
Abdominal pain, anorexia, belching, bleeding, hematemesis
Treatment Mechanisms:
Gastric acid inhibition, ulcer protection, antibacterial action
Nutrient-Drug Interactions:
Thiamin, vitamin B12, vitamin D, iron, copper deficiencies; aluminum accumulation risk in elderly
Surgical Procedures:
Billroth I, Vagotomy, Exploratory Laparotomy
Diagnostic Procedures:
Abdominal tap
Anatomical Focus:
Gastric mucosa, duodenum
Year:
2020
Region / City:
Australia
Topic:
Medical Treatment, Pharmaceutical
Document Type:
Submission
Organ / Institution:
Novartis Pharmaceuticals Australia Pty Limited
Author:
Not specified
Target Audience:
Healthcare professionals, policymakers
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2021
Region / City:
UK
Topic:
Diabetic Ketoacidosis Management
Document Type:
Guideline
Organization / Institution:
BSPED
Author:
BSPED Special Interest Group
Target Audience:
Healthcare professionals, Pediatricians, Medical teams
Period of Validity:
Ongoing
Approval Date:
2021
Revision Date:
2021
Changes Date:
May 2021
Note:
Context description
Year:
2023
Region / City:
Europe
Topic:
Diabetic foot complications, imaging
Document type:
Clinical guideline / Consensus statement
Organization:
European Association of Nuclear Medicine (EANM)
Authors:
Chiara Lauri, Edel Noriega-Álvarez, Riddhika M. Chakravartty, Olivier Gheysens, A.W.J.M Glaudemans, Riemer H.J.A. Slart, Thomas C. Kwee, Frédéric Lecouvet, Emmanouil Panagiotidis, Jules Zhang-Yin, Jose Luis Lazaro Martinez, Benjamin A. Lipsky, Luigi Uccioli, Alberto Signore
Target audience:
Nuclear medicine physicians, radiologists, diabetologists, podiatrists, infectious disease specialists
Methods:
Evidence-based recommendations using PICO strategy and Oxford Centre for Evidence-based Medicine criteria
Clinical focus:
Osteomyelitis, soft tissue infection, Charcot foot
Imaging modalities:
MRI, WBC scintigraphy, PET/CT, X-ray, SPECT/CT
Endorsing body:
EANM Inflammation and Infection Committee, Bone & Joint Committee
Description:
Evidence-based clinical guideline detailing the preferred imaging strategies for diagnosing infective and non-infective complications in diabetic foot, including osteomyelitis and soft tissue infections, based on consensus from nuclear medicine, radiology, and clinical experts.
Type of document:
Clinical service peer review questionnaire
Subject:
Multidisciplinary diabetic footcare services
Healthcare context:
Secondary and community care
Reference standards:
NICE NG19; National Diabetes Footcare Audit
Geographical context:
United Kingdom
Target audience:
MDFT members; healthcare professionals; service managers
Clinical areas covered:
Vascular surgery; orthopaedics; podiatry; infection management; outpatient and inpatient care
Service components:
Infrastructure; workforce; capacity; pathways; patient education; audit and outcomes
Time frame referenced:
Last 12 months; next five years
Year:
2021
Region / City:
Ontario
Subject:
Diabetic foot ulcers, prevention, assessment, management
Document Type:
Guideline
Author:
Expert panel on diabetic foot care
Target Audience:
Healthcare providers, long-term care organizations
Period of Application:
Ongoing
Approval Date:
Not specified
Modification Date:
Not specified
Programme:
GMS Diabetic Eye Screening Programme
Date:
3rd August 2023
Region:
Greater Manchester
Areas Covered:
Manchester; Salford; Stockport; Tameside & Glossop; Trafford
Document Type:
Official venue list
Subject:
Diabetic eye screening locations
Contact Telephone:
01614 643000
Responsible Unit:
The Bookings Team
Access Information:
D = Disabled; S = Scooter; W = Wheelchair
Screening Settings:
Community centres; opticians; health centres; churches; libraries; mobile clinics
Year:
2024-2025
Region / city:
Moshi, Tanzania
Subject:
Diabetic Macular Edema, Intravitreal Bevacizumab
Document Type:
Research Article
Organization / Institution:
Kilimanjaro Christian Medical Centre (KCMC)
Author:
Not specified
Target Audience:
Healthcare professionals, researchers in ophthalmology
Period of Application:
June 2024 - July 2025
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2026
Region / City:
Guangzhou, P. R. China
Subject:
Biomedical research, wound healing
Document Type:
Research article
Author:
Biyun Lan, Liming Zhang, Liqun Yang, Junfeng Wu, Na Li, Chenglin Pan, Xiaoyi Wang, Lexiang Zeng, Li Yan, Chuan Yang, Meng Ren
Target Audience:
Researchers in biomedical science, pharmaceutical development, and tissue engineering
Effective Period:
Ongoing study
Approval Date:
2026
Modification Date:
Not specified
Keywords:
MMP-9, siRNA, diabetic wound healing, thermosensitive hydrogel, bioengineering
Year:
2021
Region / City:
Singapore
Theme:
Diabetes management, Foot care
Document Type:
Course syllabus
Organization:
NHGP
Target Audience:
Primary care nurses, Healthcare professionals
Period of validity:
August 2021 - November 2021
Approval Date:
31 August 2021
Amendment Date:
23 November 2021
Year:
2020
Country:
Australia
Therapeutic Area:
Ophthalmology
Indication:
Diabetic macular oedema (DMO)
Active Substance:
Fluocinolone acetonide 190 microgram intravitreal implant
Brand Name:
Iluvien®
Sponsor:
Specialised Therapeutics Alim Pty Ltd
Regulatory Authority:
Pharmaceutical Benefits Advisory Committee (PBAC)
Registration Status:
TGA registered on 29 July 2019
Type of Submission:
Minor resubmission
Type of Analysis:
Cost-minimisation analysis (CMA)
Comparator:
Dexamethasone intravitreal implant
Restriction Level:
Authority Required – In Writing Only
Treatment Phase:
Initial treatment
Prescriber Type:
Medical practitioners, nurse practitioners, optometrists, midwives, dental practitioners
Program Category:
General Schedule (Code GE)
Clinical Criteria:
Visual impairment due to DMO with specified visual acuity range and prior corticosteroid treatment without significant intraocular pressure rise
Population Criteria:
Patients post-cataract surgery or scheduled for cataract surgery in the treated eye
Document Type:
Public Summary Document extract